![]() Sachi Bio Sachi Bio is a genetic tools and therapeutics company that develops nucleic acid molecules. | ![]() Adverum Biotechnologies Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases. | ![]() CAMP4 Therapeutics CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression. | |||
Founding Date | Founding Date 2019 | Founding Date 2010 | Founding Date 2006 | Founding Date 2016 | Founding Date 2016 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Erie, US HQ | Locations Redwood City, US HQ Philadelphia, US | Locations Cambridge, US HQ | Locations Cambridge, US HQ | |
Employees | Employees 7 | Employees 1,2763% decrease | Employees 11419% increase | Employees 85 | Employees 66 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.9 b | Valuation ($) 161.4 m | Valuation ($) 159.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $673m (FY, 2025) | Revenue (est.) $1m (FY, 2024) | Revenue (est.) $19.9m (FY, 2024) | Revenue (est.) $3.5m (FY, 2025) |
Net income | Net income N/A | Net income ($575m) (FY, 2025) | Net income ($130.9m) (FY, 2024) | Net income ($131.7m) (FY, 2024) | Net income ($80.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 200.1m | Total funding raised $ 70.7m | Total funding raised $ 235m | Total funding raised $ 30m |

Ultragenyx Pharmaceutical is a company that develops therapies for rare genetic diseases.
View company
Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases.
View company
Generation Bio is a genetic medicines company creating gene therapy.
View company
CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression.
View company